Abstract
To evaluate the efficacy of modified Gil-Vernet anti-reflux surgery in the treatment of patients with primary vesicoureteral reflux in a prospective historical controlled trial. A total of 30 patients with 46 refluxing units underwent this surgery since February 1998 until September 2002, with the mean follow-up period of 18 (range 6 to 43) months. Vesicoureteral reflux was resolved completely in 44 ureteral units (95.6%, p<0001). In 2 refluxing units (4.3%) in spite of reflux improvement, hydroureter remained unchanged after the surgery. In respect to response rate, there was no significant difference between different grades, genders, age groups, and laterality of primary vesicoureteral reflux. Our findings indicate that modified Gil-Vernet anti-reflux surgery which separately transfers each ureteral orifice to the tip of trigone with two fine absorbable suture on each side, is a completely successful procedure in the treatment of primary vesicoureteral reflux and produces a longer submucosal tunnel with a more suitable angel than classic Gil-Vernet procedure dose.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
